Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (5): 43-53.doi: 10.6040/j.issn.1671-7554.0.2024.0079
• Precision medicine in chronic airway diseases—Clinical Research • Previous Articles
SHI Shuochuan1*, ZENG Rong2*, ZHANG Jintao1, ZHANG Dong2, PAN Yun2, LIU Xiaofei1, XU Changjuan1, WANG Ying1, DONG Liang1,2
CLC Number:
[1] 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048. Asthma Group of Chinese Throacic Society. Guidelines for bronchial asthma prevent and management(2020 edition)Asthma Group of Chinese Throacic Society[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2020, 43(12): 1023-1048. [2] Huang KW, Yang T, Xu JY, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study[J]. Lancet, 2019, 394(10196): 407-418. [3] Kyvsgaard JN, Brustad N, Hesselberg LM, et al. Key risk factors of asthma-like symptoms are mediated through infection burden in early childhood[J]. J Allergy Clin Immunol, 2024, 153(3): 684-694. [4] Kyvsgaard JN, Chawes BL, Horner DLG, et al. Risk factors and age-related patterns of asthma-like symptoms in early childhood[J]. J Allergy Clin Immunol Pract, 2023, 11(6): 1773-1784.e10. [5] Potaczek DP, Miethe S, Schindler V, et al. Role of airway epithelial cells in the development of different asthma phenotypes[J]. Cell Signal, 2020, 69: 109523. doi:10.1016/j.cellsig.2019.109523. [6] Hammad H, Lambrecht BN. The basic immunology of asthma[J]. Cell, 2021, 184(9): 2521-2522. [7] Murphy RC, Lai Y, Liu M, et al. Distinct epithelial-innate immune cell transcriptional circuits underlie airway hyperresponsiveness in asthma[J]. Am J Respir Crit Care Med, 2023, 207(12): 1565-1575. [8] Guida G, Riccio AM. Immune induction of airway remodeling[J]. Semin Immunol, 2019, 46: 101346. doi:10.1016/j.smim.2019.101346. [9] Benson M. Clinical implications of omics and systems medicine: focus on predictive and individualized treatment[J]. J Intern Med, 2016, 279(3): 229-240. [10] Ray A, Camiolo M, Fitzpatrick A, et al. Are we meeting the promise of endotypes and precision medicine in asthma?[J]. Physiol Rev, 2020, 100(3): 983-1017. [11] Papi A, Brightling C, Pedersen SE, et al. Asthma[J]. Lancet, 2018, 391(10122): 783-800. [12] Charles D, Shanley J, Temple SN, et al. Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: a systematic review and meta-analysis[J]. Clin Exp Allergy, 2022, 52(5): 616-627. [13] Brusselle GG, Koppelman GH. Biologic therapies for severe asthma[J]. N Engl J Med, 2022, 386(2): 157-171. [14] Maglio A, Vitale C, Pellegrino S, et al. Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma[J]. Biomedicines, 2021, 9(11): 1550. doi:10.3390/biomedicines9111550. [15] Feng B, Zhou T, Guo ZY, et al. Comprehensive analysis of immune-related genes for classification and immune microenvironment of asthma[J]. Am J Transl Res, 2023, 15(2): 1052-1062. [16] Daley D, Park JE, He JQ, et al. Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes[J]. J Allergy Clin Immunol, 2012, 130(6): 1284-1293. [17] Lee CG, Link H, Baluk P, et al. Vascular endothelial growth factor(VEGF)induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung[J]. Nat Med, 2004, 10(10): 1095-1103. [18] Pilette C, Francis JN, Till SJ, et al. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge[J]. Eur Respir J, 2004, 23(6): 876-884. [19] Lo CY, Michaeloudes C, Bhavsar PK, et al. Increased phenotypic differentiation and reduced corticosteroid sensitivity of fibrocytes in severe asthma[J]. J Allergy Clin Immunol, 2015, 135(5): 1186-1195.e1-6. [20] Camiolo MJ, Zhou XX, Wei Q, et al. Machine learning implicates the IL-18 signaling axis in severe asthma[J]. JCI Insight, 2021, 6(21): e149945. doi:10.1172/jci.insight.149945. [21] Liu Y, Xu K, Yao Y, et al. Current research into A20 mediation of allergic respiratory diseases and its potential usefulness as a therapeutic target[J]. Front Immunol, 2023, 14: 1166928. doi:10.3389/fimmu.2023.1166928. [22] Poto R, Criscuolo G, Marone G, et al. Human lung mast cells: therapeutic implications in asthma[J]. Int J Mol Sci, 2022, 23(22): 14466. doi:10.3390/ijms232214466. [23] Siddiqui S, Bachert C, Bjermer L, et al. Eosinophils and tissue remodeling: relevance to airway disease[J]. J Allergy Clin Immunol, 2023, 152(4): 841-857. [24] Felton JM, Dorward DA, Cartwright JA, et al. Mcl-1 protects eosinophils from apoptosis and exacerbates allergic airway inflammation[J]. Thorax, 2020, 75(7): 600-605. [25] van der Veen TA, de Groot LES, Melgert BN. The different faces of the macrophage in asthma[J]. Curr Opin Pulm Med, 2020, 26(1): 62-68. [26] Abdelaziz MH, Abdelwahab SF, Wan J, et al. Alternatively activated macrophages; a double-edged sword in allergic asthma[J]. J Transl Med, 2020, 18(1): 58. doi:10.1186/s12967-020-02251-w. [27] Mamessier E, Nieves A, Lorec AM, et al. T-cell activation during exacerbations: a longitudinal study in refractory asthma[J]. Allergy, 2008, 63(9): 1202-1210. [28] Smyth LJ, Eustace A, Kolsum U, et al. Increased airway T regulatory cells in asthmatic subjects[J]. Chest, 2010, 138(4): 905-912. [29] Boonpiyathad T, Capova G, Duchna HW, et al. Impact of high-altitude therapy on type-2 immune responses in asthma patients[J]. Allergy, 2020, 75(1): 84-94. [30] Boonpiyathad T, Sokolowska M, Morita H, et al. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy[J]. Allergy, 2019, 74(5): 976-985. [31] Xie Y, Abel PW, Casale TB, et al. TH17 cells and corticosteroid insensitivity in severe asthma[J]. J Allergy Clin Immunol, 2022, 149(2): 467-479. [32] Vollmer CM, Dias ASO, Lopes LM, et al. Leptin favors Th17/Treg cell subsets imbalance associated with allergic asthma severity[J]. Clin Transl Allergy, 2022, 12(6): e12153. doi:10.1002/clt2.12153. [33] Lin K, Wang T, Tang QQ, et al. IL18R1-related molecules as biomarkers for asthma severity and prognostic markers for idiopathic pulmonary fibrosis[J]. J Proteome Res, 2023, 22(10): 3320-3331. [34] Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine[J]. Int Immunol, 1999, 11(1): 81-88. [35] Nakano K, Whitehead GS, Lyons-Cohen MR, et al. Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation[J]. J Allergy Clin Immunol, 2024, 153(2): 487-502.e9. [36] Fainaru O, Shseyov D, Hantisteanu S, et al. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease[J]. Proc Natl Acad Sci U S A, 2005, 102(30): 10598-10603. |
[1] | WANG Ting, ZHANG Li, WANG Gang. Neuropsychological asthma [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 28-34. |
[2] | DING Yiren, LIU Wanying, YAO Lei, YAO Xin. Research progress of the treatment of asthma with macrolide antibiotics [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 21-27. |
[3] | MENG Jianli, WANG Qinggang. Expression and potential mechanism of VPS72 in lung adenocarcinoma/ squamous cell carcinoma by integrated bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2023, 61(8): 40-49. |
[4] | CHANG Qing, LIU Jia, QU Ailin, YANG Yongmei. Association of NAMPT with pathological features and immune infiltration of hepatocellular carcinoma using database information [J]. Journal of Shandong University (Health Sciences), 2023, 61(4): 26-36. |
[5] | LI Linlin, WANG Kai. Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 50-58. |
[6] | XIU Dejian, GAO Zhengwen, SONG Tingting, CUI Nan, CUI Jing, SUN Jianping. Genes associated with cervical cancer by integrated bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 99-109. |
[7] | YANG Liping, MU Tingting, YANG Yujuan, ZHANG Yu, SONG Xicheng. Effects of inhaled allergens on pulmonary function in children with adenoid hypertrophy complicated with bronchial asthma [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 107-112. |
[8] | PAN Shiyang. Research advances in markers for the evaluation of lung cancer efficacy [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 31-39. |
[9] | GAO Chunfang, HUANG Chenjun. Cancer biomarkers of intrahepatic cholangiocarcinoma and the clinical application [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 24-30. |
[10] | WANG Hongyang. Development of tumor biomarkers in the age of precision medicine [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 1-2. |
[11] | LIU Xiaojuan, DING Lijie, KANG Fengling, ZHOU Miao, XUE Fuzhong. A prediction model for bronchial asthma risk based on a health management population [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 56-61. |
[12] | DU Yifeng, JING Ran. Diagnosis and treatment of Alzheimers disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 7-13. |
[13] | FANG Qian, QU Ailin, ZHANG Xin, DU Lutao, YANG Yongmei, WANG Chuanxin. Expression and clinical significance of miR-210 in the serum of patients with colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 77-81. |
[14] | GAO Nannan, CHEN Dong, YU Yonghui, ZHANG Lili. Significance of different biomarkers on assessing the surgical treatment of necrotizing enterocolitis in the newborn [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 73-76. |
[15] | WANG Dexiang1, JI Xiu-li1,2, MA Dedong1, ZHANG Yu-ke1, HE Bao-long1, WANG Wen-qiao1, XIAO Wei1. The economic burden of bronchial asthma and its related factors in Jinan [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 124-128. |
|